Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2010

01.01.2010

Clinical Characteristics and Genotype-phenotype Correlation in 62 Patients with X-linked Agammaglobulinemia

verfasst von: Pamela P. W. Lee, Tong-Xin Chen, Li-Ping Jiang, Koon-Wing Chan, Wanling Yang, Bee-Wah Lee, Wen-Chin Chiang, Xiang-Yuan Chen, Susanna F. S. Fok, Tsz-Leung Lee, Marco H. K. Ho, Xi-Qiang Yang, Yu-Lung Lau

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

X-linked agammagobulinemia (XLA) is a primary immunodeficiency disorder caused by Bruton's tyrosine kinase (Btk) gene mutation. Recent studies suggested genotype-phenotype correlation in XLA, but a definitive association remains controversial.

Patients and Methods

We examined the relationship between specific Btk gene mutations and severity of clinical presentation in 62 patients with XLA. Disease severity was assessed by the age of disease onset and the presence of severe infections, while mutations were classified into severe and mild based on structural and functional consequence by bioinformatics analysis.

Results

Fifty-six Btk mutations were identified in 62 patients from 57 kindreds. Variation in phenotypes was observed, and there was a tendency of association between genotype and age of disease onset as well as occurrence of severe infections.

Conclusion

A critical analysis of the circumstances upon presentation also revealed that under-recognition of recurrent infections and relevant family history are important hurdles to timely diagnosis of XLA.
Literatur
1.
Zurück zum Zitat Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199–227.CrossRefPubMed Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199–227.CrossRefPubMed
2.
Zurück zum Zitat Vetrie D, Vorechovský I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993;361:226–33.CrossRefPubMed Vetrie D, Vorechovský I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993;361:226–33.CrossRefPubMed
3.
Zurück zum Zitat Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine. 1985;64:145–56.CrossRefPubMed Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine. 1985;64:145–56.CrossRefPubMed
4.
Zurück zum Zitat Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86:31–42.PubMed Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86:31–42.PubMed
5.
Zurück zum Zitat Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr. 2002;141:566–71.CrossRefPubMed Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr. 2002;141:566–71.CrossRefPubMed
6.
Zurück zum Zitat Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States Registry of 201 patients. Medicine. 2006;85:193–202.CrossRefPubMed Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States Registry of 201 patients. Medicine. 2006;85:193–202.CrossRefPubMed
7.
Zurück zum Zitat Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: An Italian multicenter study. Clin Immunol. 2002;104:221–30.CrossRefPubMed Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: An Italian multicenter study. Clin Immunol. 2002;104:221–30.CrossRefPubMed
8.
Zurück zum Zitat López-Granados E, Pérez de Diego R, Ferreira Cerdán A, Fontán Casariego G, García Rodríguez MC. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J Allergy Clin Immunol. 2005;116:690–7.CrossRefPubMed López-Granados E, Pérez de Diego R, Ferreira Cerdán A, Fontán Casariego G, García Rodríguez MC. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J Allergy Clin Immunol. 2005;116:690–7.CrossRefPubMed
9.
Zurück zum Zitat Broides A, Yang W, Conley ME. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol. 2006;118:195–200.CrossRefPubMed Broides A, Yang W, Conley ME. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol. 2006;118:195–200.CrossRefPubMed
10.
Zurück zum Zitat Holinski-Feder E, Weiss M, Brandau O, Jedele KB, Nore B, Bäckesjö CM, et al. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics. 1998;101:276–84.CrossRefPubMed Holinski-Feder E, Weiss M, Brandau O, Jedele KB, Nore B, Bäckesjö CM, et al. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics. 1998;101:276–84.CrossRefPubMed
11.
Zurück zum Zitat Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617–9.CrossRefPubMed Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617–9.CrossRefPubMed
12.
Zurück zum Zitat Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190–7.CrossRefPubMed Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190–7.CrossRefPubMed
13.
Zurück zum Zitat Yip KL, Chan SY, Ip WK, Lau YL. Bruton’s tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia. Hum Mutat. 2000;15:385.CrossRefPubMed Yip KL, Chan SY, Ip WK, Lau YL. Bruton’s tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia. Hum Mutat. 2000;15:385.CrossRefPubMed
14.
Zurück zum Zitat Chan KW, Chen T, Jiang L, Fok SF, Lee TL, Lee BW, et al. Identification of Bruton tyrosine kinase mutations in 12 Chinese patients with X-linked agammaglobulinaemia by long PCR-direct sequencing. Int J Immunogenet. 2006;33:205–9.CrossRefPubMed Chan KW, Chen T, Jiang L, Fok SF, Lee TL, Lee BW, et al. Identification of Bruton tyrosine kinase mutations in 12 Chinese patients with X-linked agammaglobulinaemia by long PCR-direct sequencing. Int J Immunogenet. 2006;33:205–9.CrossRefPubMed
15.
Zurück zum Zitat Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev. 2005;203:216–34.CrossRefPubMed Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev. 2005;203:216–34.CrossRefPubMed
16.
Zurück zum Zitat Väliaho J, Smith CI, Vihinen M. BTKbase: the mutation database for X-linked agammaglobulinemia. Hum Mutat. 2006;27:1209–17. BTKbase: mutation registry for X-linked agammaglobulinemia (XLA), version 8.5 (last updated 21 August, 2008). Available from http://bioinf.uta.fi/BTKbase.CrossRefPubMed Väliaho J, Smith CI, Vihinen M. BTKbase: the mutation database for X-linked agammaglobulinemia. Hum Mutat. 2006;27:1209–17. BTKbase: mutation registry for X-linked agammaglobulinemia (XLA), version 8.5 (last updated 21 August, 2008). Available from http://​bioinf.​uta.​fi/​BTKbase.CrossRefPubMed
17.
Zurück zum Zitat Mattsson PT, Vihinen M, Smith CI. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease. Bioessays. 1996;18:825–34.CrossRefPubMed Mattsson PT, Vihinen M, Smith CI. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease. Bioessays. 1996;18:825–34.CrossRefPubMed
21.
Zurück zum Zitat Kojima T, Fukuda M, Watanabe Y, Hamazato F, Mikoshiba K. Characterization of the pleckstrin homology domain of Btk as an inositol polyphosphate and phosphoinositide binding domain. Biochem Biophys Res Commun. 1997;236:333–9.CrossRefPubMed Kojima T, Fukuda M, Watanabe Y, Hamazato F, Mikoshiba K. Characterization of the pleckstrin homology domain of Btk as an inositol polyphosphate and phosphoinositide binding domain. Biochem Biophys Res Commun. 1997;236:333–9.CrossRefPubMed
22.
Zurück zum Zitat Hanks SK. Genomic analysis of the eukaryotic protein kinase superfamily: a perspective. Genome Biol. 2003;4:111.CrossRefPubMed Hanks SK. Genomic analysis of the eukaryotic protein kinase superfamily: a perspective. Genome Biol. 2003;4:111.CrossRefPubMed
23.
Zurück zum Zitat Shen B, Vihinen M. Conservation and covariance in PH domain sequences: physicochemical profile and information theoretical analysis of XLA-causing mutations in the Btk PH domain. Protein Eng Des Sel. 2004;17:267–76.CrossRefPubMed Shen B, Vihinen M. Conservation and covariance in PH domain sequences: physicochemical profile and information theoretical analysis of XLA-causing mutations in the Btk PH domain. Protein Eng Des Sel. 2004;17:267–76.CrossRefPubMed
24.
Zurück zum Zitat Baraldi E, Djinovic Carugo K, Hyvönen M. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate. Structure. 1999;7:449–60.CrossRefPubMed Baraldi E, Djinovic Carugo K, Hyvönen M. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate. Structure. 1999;7:449–60.CrossRefPubMed
25.
Zurück zum Zitat Lindvall JM, Blomberg KE, Väliaho J, Vargas L, Heinonen JE, Berglöf A, et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol Rev. 2005;203:200–15.CrossRefPubMed Lindvall JM, Blomberg KE, Väliaho J, Vargas L, Heinonen JE, Berglöf A, et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol Rev. 2005;203:200–15.CrossRefPubMed
26.
Zurück zum Zitat Rawlings DJ, Saffran DC, Tsukada S, et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993;261:358–61.CrossRefPubMed Rawlings DJ, Saffran DC, Tsukada S, et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993;261:358–61.CrossRefPubMed
27.
Zurück zum Zitat Lappalainen I, Thusberg J, Shen B, Vihinen M. Genome wide analysis of pathogenic SH2 domain mutations. Proteins. 2008;72:779–92.CrossRefPubMed Lappalainen I, Thusberg J, Shen B, Vihinen M. Genome wide analysis of pathogenic SH2 domain mutations. Proteins. 2008;72:779–92.CrossRefPubMed
28.
Zurück zum Zitat Wang Y, Kanegane H, Wang X, Han X, Zhang Q, Zhao S, et al. Mutation of the BTK gene and clinical features of X-linked agammaglobulinemia in mainland China. J Clin Immunol. 2009;29:352–6.CrossRefPubMed Wang Y, Kanegane H, Wang X, Han X, Zhang Q, Zhao S, et al. Mutation of the BTK gene and clinical features of X-linked agammaglobulinemia in mainland China. J Clin Immunol. 2009;29:352–6.CrossRefPubMed
29.
Zurück zum Zitat He J, Zhao S, Jiang Z. Clinical features of 17 cases of X-linked agammaglobulinemia. Chin J Contemp Pediatr. 2008;10:139–42. He J, Zhao S, Jiang Z. Clinical features of 17 cases of X-linked agammaglobulinemia. Chin J Contemp Pediatr. 2008;10:139–42.
30.
Zurück zum Zitat Chun JK, Lee TJ, Song JW, Linton JA, Kim DS. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital. Yonsei Med J. 2008;49:28–36.CrossRefPubMed Chun JK, Lee TJ, Song JW, Linton JA, Kim DS. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital. Yonsei Med J. 2008;49:28–36.CrossRefPubMed
31.
Zurück zum Zitat Kanavaros P, Rontogianni D, Hrissovergi D, Efthimiadoy A, Argyrakos T, Mastoris K, et al. Extranodal cytotoxic T-cell lymphoma in a patient with X-linked agammaglobulinaemia. Leuk Lymphoma. 2001;42:235–8.CrossRefPubMed Kanavaros P, Rontogianni D, Hrissovergi D, Efthimiadoy A, Argyrakos T, Mastoris K, et al. Extranodal cytotoxic T-cell lymphoma in a patient with X-linked agammaglobulinaemia. Leuk Lymphoma. 2001;42:235–8.CrossRefPubMed
Metadaten
Titel
Clinical Characteristics and Genotype-phenotype Correlation in 62 Patients with X-linked Agammaglobulinemia
verfasst von
Pamela P. W. Lee
Tong-Xin Chen
Li-Ping Jiang
Koon-Wing Chan
Wanling Yang
Bee-Wah Lee
Wen-Chin Chiang
Xiang-Yuan Chen
Susanna F. S. Fok
Tsz-Leung Lee
Marco H. K. Ho
Xi-Qiang Yang
Yu-Lung Lau
Publikationsdatum
01.01.2010
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2010
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9341-5

Weitere Artikel der Ausgabe 1/2010

Journal of Clinical Immunology 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.